Latest Period
Q1 2026
Security Snapshot
RedHill Biopharma Ltd. - American Depositary Shares (RDHL) Institutional Ownership
CUSIP: 757468301
13F Institutional Holders and Ownership History from Q3 2024 to Q2 2026
Institutions Reporting
15
Shares (Excl. Options)
518,656
Price
$0.75
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / American Depositary Shares
- Symbol
- RDHL on Nasdaq
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 518,656
- Total 13F value
- $386,495
- Portfolio coverage rank
- 0%
- Share change
- +19,181
- Value change
- +$14,188
- Number of holders
- 15
- Shares outstanding
- 5,138,616
- SEC-reported price per share
- $0.87
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
2 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- RDHL - RedHill Biopharma Ltd. - American Depositary Shares is tracked under CUSIP 757468301.
- 15 institutions reported positions in Q1 2026.
- 2 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 15 to 3 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $386,495 to $5,894.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 15 institutions filings for Q1 2026.
Security key
757468301
Latest holder period
Q1 2026
13F holders
15
13D/G owners
2
CIK / CUSIP context first
Open Q1 2026 holders
RDHL full holder history
RedHill Biopharma Ltd. SEC filings
RedHill Biopharma Ltd. company facts
RedHill Biopharma Ltd. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 757468301:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
2
Security
RDHL
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| YA II PN, Ltd. | 9.9% | $559,595 | 508,723 | YA II PN, Ltd. | 19 Dec 2025 | |||
| Alumni Capital LP | 10% | $801,687 | 369,373 | Alumni Capital LP | 20 Jun 2025 |
As of 31 Mar 2026, 15 institutional investors reported holding 518,656 shares of RedHill Biopharma Ltd. - American Depositary Shares (RDHL). This represents 10% of the company’s total 5,138,616 outstanding shares.
13F concentration
Top 19 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
10%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Yorkville Advisors Global, LP | 6.8% | 350,870 | -9.2% | 0.18% | $261,468 |
| GAGNON SECURITIES LLC | 1.7% | 88,405 | +2.7% | 0.02% | $65,879 |
| CITADEL ADVISORS LLC | 0.4% | 20,673 | +34% | 0% | $15,406 |
| XTX Topco Ltd | 0.3% | 15,163 | 0% | $11,299 | |
| StoneX Group Inc. | 0.28% | 14,481 | 0% | $10,791 | |
| TWO SIGMA SECURITIES, LLC | 0.25% | 13,019 | 0% | $9,702 | |
| GAMMA Investing LLC | 0.13% | 6,684 | +38% | 0% | $4,981 |
| RHUMBLINE ADVISERS | 0.1% | 5,116 | +91% | 0% | $3,807 |
| Federation des caisses Desjardins du Quebec | 0.07% | 3,388 | 0% | 0% | $2,524 |
| UBS Group AG | 0.02% | 826 | +4489% | 0% | $615 |
| Your Advocates Ltd., LLP | 0% | 19 | 0% | 0% | $14 |
| Smartleaf Asset Management LLC | 0% | 5 | 0% | 0% | $4 |
| SBI Securities Co., Ltd. | 0% | 4 | 0% | 0% | $3 |
| Vermillion Wealth Management, Inc. | 0% | 2 | 0% | 0% | $1 |
| MORGAN STANLEY | 0% | 1 | 0% | 0% | $1 |
| EverSource Wealth Advisors, LLC | 0% | 0 | -100% | $0 | |
| GROUP ONE TRADING LLC | 0% | 0 | -100% | $0 | |
| BANK OF AMERICA CORP /DE/ | 0% | 0 | -100% | $0 | |
| Garton & Associates Financial Advisors LLC | 0% | 0 | -100% | $0 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
8
Latest
Q1 2026
Rows shown
1-8 of 8
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 6,974 | $5,894 | +$241 | $0.87 | 3 |
| 2026 Q1 | 518,656 | $386,495 | +$14,188 | $0.75 | 15 |
| 2025 Q4 | 499,475 | $514,455 | +$490,133 | $1.03 | 16 |
| 2025 Q3 | 23,584 | $51,175 | +$9,088 | $2.17 | 13 |
| 2025 Q2 | 19,540 | $37,852 | -$36,277 | $1.94 | 11 |
| 2025 Q1 | 30,251 | $80,464 | +$34,765 | $2.66 | 11 |
| 2024 Q4 | 16,679 | $103,485 | +$68,875 | $6.17 | 10 |
| 2024 Q3 | 5,579 | $48,750 | +$48,750 | $8.73 | 8 |